| Pharma Licensing |
|
|
| Written by Administrator | |
| Wednesday, 13 June 2007 | |
Licensing of Pharmaceutical Products
Fop more details please visit the sections about: Database with offers for out-licensing
Licensing has emerged as a critical pharma industry mechanism through which more specialized companies are able to compete effectively across the pharmaceutical value chain. Critical mass in sales and marketing within and across markets is derived through out-licensing. Database with demand for in-licensingIn-licensing is used to expand or restructure company product portfolio. It is valuable plug for gaps in pipeline resulting from declining R&D productivity. It could cut R&D timelines and costs. New technologies and expertise are accessed through risk and cost sharing licensing agreements, Database with Contract Research Services (CRO)New specialized technology companies have introduced biotechnology and drug delivery technology to the traditional pharmaceutical value chain. Developing access to new genomics technologies has impacted all R&D pharmaceutical companies. These new technologies and expertise are accessed through risk and cost sharing licensing agreements, Register yourself to the network and publish your offer or demand! Registration is FREE. |
|
| Last Updated ( Thursday, 07 February 2008 ) |
|
The leader shows that style is no substitute for substance, that creating an impression is not more potent than acting from one's center. Lao Tzu |